<!DOCTYPE html>
<html lang="en" dir="auto" data-theme="auto">

<head><script src="/livereload.js?mindelay=10&amp;v=2&amp;port=1313&amp;path=livereload" data-no-instant defer></script><meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="noindex, nofollow">
<title>MannLabs @2025 | MannLabs</title>
<meta name="keywords" content="">
<meta name="description" content="The Year 2025 in Review">
<meta name="author" content="MannLabs">
<link rel="canonical" href="//localhost:1313/2025/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.a5781257de4197b8e3d54346acdf1dd55a9ba4cb91dcace192fc1baf228c08b5.css" integrity="sha256-pXgSV95Bl7jj1UNGrN8d1VqbpMuR3KzhkvwbryKMCLU=" rel="preload stylesheet" as="style">
<link rel="icon" href="//localhost:1313/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="//localhost:1313/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="//localhost:1313/favicon-32x32.png">
<link rel="apple-touch-icon" href="//localhost:1313/apple-touch-icon.png">
<link rel="mask-icon" href="//localhost:1313/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<link rel="alternate" type="application/rss+xml" href="//localhost:1313/2025/index.xml" title="rss">
<link rel="alternate" hreflang="en" href="//localhost:1313/2025/">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --code-block-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
                color-scheme: dark;
            }

            .list {
                background: var(--theme);
            }

            .toc {
                background: var(--entry);
            }
        }

        @media (prefers-color-scheme: light) {
            .list::-webkit-scrollbar-thumb {
                border-color: var(--code-bg);
            }
        }

    </style>
</noscript>
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.querySelector("html").dataset.theme = 'dark';
    } else if (localStorage.getItem("pref-theme") === "light") {
       document.querySelector("html").dataset.theme = 'light';
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.querySelector("html").dataset.theme = 'dark';
    } else {
        document.querySelector("html").dataset.theme = 'light';
    }

</script><style>
:root {
    --main-width: min(900px, 100vw - 2 * var(--gap, 24px));
}

@media (max-width: 768px) {
    :root {
        --main-width: calc(100vw - 2 * var(--gap, 24px));
    }
}
</style>

</head>
<body class="list" id="top">
    <header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="//localhost:1313/" accesskey="h" title="MannLabs (Alt + H)">MannLabs</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)" aria-label="Toggle theme">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
            <li>
                <a href="//localhost:1313/2025/" title="2025">
                    <span class="active">2025</span>
                </a>
            </li>
        </ul>
    </nav>
</header>
<main class="main"> 
<header class="page-header">
  <h1>
    MannLabs @2025
  </h1>
  <div class="post-description">
    The Year 2025 in Review
  </div>
</header>
<div class="post-content"><h2 id="overview">Overview<a hidden class="anchor" aria-hidden="true" href="#overview">#</a></h2>
<p>2025 has been an exceptional year for the Mann Lab, with major
publications in Nature (3), Nature Biotechnology, Nature Genetics,
Nature Protocols, Nature Communications, Cancer Cell, Cell, Cell
Systems, EMBO Molecular Medicine, and Molecular Cell among others. Our
work continues to advance mass spectrometry-based proteomics technology
while translating these capabilities into clinical and biological
applications.</p>
<table>
  <thead>
      <tr>
          <th>Last/Senior Author Papers (Published)</th>
          <th>18+</th>
      </tr>
  </thead>
  <tbody>
      <tr>
          <td>Preprints (bioRxiv/medRxiv)</td>
          <td>9+</td>
      </tr>
      <tr>
          <td>Nature family papers</td>
          <td>7</td>
      </tr>
      <tr>
          <td>Major Collaborations</td>
          <td>6+</td>
      </tr>
  </tbody>
</table>
<h2 id="technology-advances">Technology Advances<a hidden class="anchor" aria-hidden="true" href="#technology-advances">#</a></h2>
<h3 id="proteomics-methods">Proteomics Methods<a hidden class="anchor" aria-hidden="true" href="#proteomics-methods">#</a></h3>
<ul>
<li>
<p><strong>SPEC (Solid-Phase Extraction Capture)</strong> Heymann T, Oliinyk D,
Henneberg L, et al. <em>bioRxiv 2025.05.31.657165</em> Nanoliter-volume
workflow for fast, robust and ultrasensitive proteomics enabling
unprecedented sensitivity from minimal sample input.</p>
</li>
<li>
<p><strong>PCA-N Workflow for Plasma Proteomics</strong> Albrecht V, Müller-Reif JB,
Brennsteiner V, Mann M <em>Mol Cell Proteomics. 2025 Nov;24(11):101071</em>
Simplified perchloric acid workflow enabling deep plasma proteomics
at population scale with &gt;10,000 samples per day throughput.</p>
</li>
<li>
<p><strong>nanoPhos &ndash; Spatial Phosphoproteomics</strong> Oliinyk D, Heymann T,
Henneberg L, et al. <em>bioRxiv 2025.05.29.656770</em> Ultra-sensitive
cell-type resolved spatial phosphoproteomics enabling signaling
analysis at single-cell resolution in tissues.</p>
</li>
<li>
<p><strong>PASEF Workflow Protocol</strong> Skowronek P, Wallmann G, Wahle M,
Willems S, Mann M <em>Nat Protoc. 2025 Jun;20(6):1700-1729</em> Accessible
step-by-step protocol for high-sensitivity proteomics using parallel
accumulation-serial fragmentation.</p>
</li>
<li>
<p><strong>Stellar MS for Biomarker Translation</strong> Wahle M, Remes PM, Albrecht
V, et al., Mann M <em>Mol Cell Proteomics. 2025 Sep;24(9):101050</em> Novel
hybrid high-speed mass spectrometer enables rapid translation from
biomarker candidates to targeted clinical tests using 15N-labeled
proteins.</p>
</li>
<li>
<p><strong>Pre-Analytical Drivers of Bias in Plasma Proteomics</strong> Korff K,
Müller-Reif JB, et al., Mann M, Geyer PE <em>EMBO Mol Med. 2025
Nov;17(11):3174-3196</em> Systematic evaluation of plasma proteomics
workflows reveals susceptibility to cellular contamination and
provides framework for quality control.</p>
</li>
</ul>
<h2 id="bioinformatics--software">Bioinformatics &amp; Software<a hidden class="anchor" aria-hidden="true" href="#bioinformatics--software">#</a></h2>
<ul>
<li>
<p><strong>AlphaDIA &ndash; Transfer Learning for DIA</strong> Wallmann G, Skowronek P,
Brennsteiner V, et al., Mann M <em>Nat Biotechnol. 2025 Oct 21</em>
End-to-end transfer learning enabling feature-free proteomics with
dramatically improved identification rates.</p>
</li>
<li>
<p><strong>ADAPT-MS &ndash; Adaptive Clinical Diagnostics</strong> Müller-Reif JB,
Albrecht V, Brennsteiner V, et al., Wewer Albrechtsen NJ, Mann M <em>In
press at Nature Communications (medRxiv 2025.05.02.25326901)</em>
Framework enabling direct diagnostic interpretation of
discovery-mode proteomics data for personalized testing.</p>
</li>
<li>
<p><strong>scPortrait &ndash; Single-Cell Image Integration</strong> Mädler SC, Schmacke
NA, Palma A, et al., Theis FJ, Mann M <em>bioRxiv 2025.09.22.677590</em>
Software package for generation, storage and application of
single-cell image datasets enabling multimodal analysis.</p>
</li>
<li>
<p><strong>Tree-based Proteoform Quantification</strong> Ammar C, Thielert M, Weiss
CAM, et al., Mann M <em>bioRxiv 2025.03.06.641844</em> Novel computational
approach to infer proteoform regulation from bottom-up proteomics
data.</p>
</li>
<li>
<p><strong>AI Laboratory Agents</strong> Skowronek P, Nawalgaria A, Mann M <em>Mol Syst
Biol. 2025 Dec</em> Multimodal AI agents for capturing and sharing tacit
laboratory practice through video, speech, and text analysis.</p>
</li>
</ul>
<h2 id="high-throughput-applications">High-Throughput Applications<a hidden class="anchor" aria-hidden="true" href="#high-throughput-applications">#</a></h2>
<h3 id="clinical--population-proteomics">Clinical &amp; Population Proteomics<a hidden class="anchor" aria-hidden="true" href="#clinical--population-proteomics">#</a></h3>
<ul>
<li>
<p><strong>Plasma Proteome in Children and Adolescents</strong> Niu L, Stinson SE,
Holm LA, et al., Mann M <em>Nat Genet. 2025 Feb 19</em> Comprehensive
proteomic profiling of 2,147 children revealing associations with
age, sex, puberty, BMI, and genetics.</p>
</li>
<li>
<p><strong>MS-based Proteomics: Single Cells to Clinical Applications</strong> Guo
T, Steen JA, Mann M <em>Nature. 2025 Feb;638(8052):901-911</em> Major
review article charting the path from technological advances to
clinical implementation of proteomics.</p>
</li>
<li>
<p><strong>Ontology-guided Clustering for Rare Pediatric Disorders</strong> Itang
ECM, Albrecht V, et al., Mann M, Pangratz-Fuehrer S, Mueller-Reif JB
<em>EMBO Mol Med. 2025 Jul;17(7):1842-1867</em> Framework integrating
clinical ontologies with proteomics enables analysis of 394 rare
pediatric conditions from 1,140 patients.</p>
</li>
</ul>
<h3 id="disease-biology--spatial-proteomics">Disease Biology &amp; Spatial Proteomics<a hidden class="anchor" aria-hidden="true" href="#disease-biology--spatial-proteomics">#</a></h3>
<ul>
<li>
<p><strong>Alpha-1 Antitrypsin Deficiency &ndash; Liver Disease</strong> Rosenberger FA,
Mädler SC, et al., Mann M <em>Nature. 2025 Apr 16</em> Deep Visual
Proteomics reveals why some patients with the hereditary liver
disease remain healthy while others develop severe pathology.</p>
</li>
<li>
<p><strong>Liver Zonation and Fibrosis</strong> Weiss CAM, Brown LA, Miranda L, et
al., Rosenberger FA, Mann M <em>bioRxiv 2025.04.13.648568</em> Single cell
spatial proteomics maps human hepatocyte zonation patterns and their
vulnerability to fibrosis.</p>
</li>
<li>
<p><strong>Colon Organoid Models</strong> Post F, Hausmann A, et al., Mann M <em>Cell
Syst. 2025 Sep 17;16(9):101396</em> DVP reveals in vivo-like phenotype
upon xenotransplantation of human colon organoids.</p>
</li>
<li>
<p><strong>Pancreatic Islet Cell Diversity</strong> Thielert M, Villalba A, et al.,
Mann M, Scharfmann R <em>Commun Biol. 2025 Oct 17;8(1):1483</em> Cell
type-resolved proteomics and phosphoproteomics decode adult murine
pancreatic islet cell diversity.</p>
</li>
<li>
<p><strong>Signet Ring Cell Carcinoma</strong> Kabatnik S, Zheng X, et al., Mann M
<em>NPJ Precis Oncol. 2025 Feb 5;9(1):37</em> DNA replication stress
identified as a hallmark of signet ring cell carcinoma through DVP.</p>
</li>
<li>
<p><strong>Tumor-Immune Crosstalk</strong> Zheng X, Mund A, Mann M <em>Mol Cell. 2025
Mar 6;85(5):1008-1023.e7</em> Deciphering functional tumor-immune
crosstalk through highly multiplexed imaging and deep visual
proteomics.</p>
</li>
</ul>
<h2 id="major-collaborations">Major Collaborations<a hidden class="anchor" aria-hidden="true" href="#major-collaborations">#</a></h2>
<h3 id="ovarian-cancer--ernst-lengyel-u-chicago">Ovarian Cancer &ndash; Ernst Lengyel (U. Chicago)<a hidden class="anchor" aria-hidden="true" href="#ovarian-cancer--ernst-lengyel-u-chicago">#</a></h3>
<ul>
<li>
<p><strong>Borderline Ovarian Tumor Progression (LGSC)</strong> Schweizer L, Kenny
HA, et al., Mann M, Lengyel E <em>Cancer Cell. 2025 Jun 20</em> Spatial
proteo-transcriptomics reveals molecular landscape of borderline
ovarian tumors. Identified 16 drug targets; combination therapy
achieved significant tumor reduction.</p>
</li>
<li>
<p><strong>Early Ovarian Cancer Mechanisms (HGSC)</strong> Metousis A, Kenny HA,
Shimizu A, et al., Mann M, Lengyel E <em>medRxiv 2025.08.25.25333715</em>
Integration of cell-type resolved spatial proteomics and
transcriptomics reveals novel mechanisms including SUMOylation
activation and ATR signaling.</p>
</li>
<li>
<p><strong>NNMT Inhibition Restores Antitumor Immunity</strong> Heide J, Bilecz AJ,
et al., Mann M, ..., Lengyel E <em>Nature. 2025
Sep;645(8082):1051-1059</em> NNMT inhibitor reduces tumor burden by
reprogramming cancer-associated fibroblasts and restoring immune
checkpoint blockade efficacy.</p>
</li>
<li>
<p><strong>3D Multi-omic Mapping of Fallopian Tubes (STIC)</strong> Metousis A, et
al., Mann M, Lengyel E <em>bioRxiv 2025.09.21.677628</em> Spatially
resolved multi-omics framework identifies 99 STICs and precursors in
cancer-free organ donors, revealing high incidence of ovarian cancer
precursors.</p>
</li>
</ul>
<h3 id="clinical-proteomics--nicolai-wewer-albrechtsen-copenhagen">Clinical Proteomics &ndash; Nicolai Wewer Albrechtsen (Copenhagen)<a hidden class="anchor" aria-hidden="true" href="#clinical-proteomics--nicolai-wewer-albrechtsen-copenhagen">#</a></h3>
<ul>
<li>
<p><strong>ADAPT-MS Clinical Framework</strong> Müller-Reif JB, Albrecht V, et al.,
Wewer Albrechtsen NJ, Mann M <em>In press at Nature Communications</em>
Adaptive diagnostic framework for clinical proteomics enabling
personalized testing from plasma and CSF.</p>
</li>
<li>
<p><strong>Benzon Symposium: Bridging Technology to Clinical Application</strong>
Albrecht V, Müller-Reif J, et al., Wewer Albrechtsen NJ, Mann M <em>Mol
Cell Proteomics. 2024 Dec;23(12):100877</em> Report on advances in
clinical proteomics and translational strategies from the 68th
Benzon Foundation Symposium.</p>
</li>
</ul>
<h3 id="other-key-collaborations">Other Key Collaborations<a hidden class="anchor" aria-hidden="true" href="#other-key-collaborations">#</a></h3>
<ul>
<li>
<p><strong>GPX4 and Ferroptosis in Neurodegeneration</strong> Lorenz SM, et al.,
Mann M, ..., Conrad M <em>Cell. 2025 Dec (with Marcus Conrad,
Helmholtz Munich)</em> A fin-loop-like structure in GPX4 underlies
neuroprotection from ferroptosis. Proteomics revealed
Alzheimer's-like signatures.</p>
</li>
<li>
<p><strong>LRRK2 and Crohn's Disease/Colitis</strong> Heaton GR, et al., Mann M,
..., Yue Z <em>J Clin Invest. 2025 Oct (with Zhenyu Yue, Mount Sinai)</em>
Targeting specific LRRK2 kinase substrates rescues colitis severity
caused by Crohn's disease-linked variant.</p>
</li>
<li>
<p><strong>GID E3 Ligase Complex</strong> Schulman lab with Mann lab proteomics
<em>Multiple papers ongoing</em> Continued collaboration on ubiquitin
signaling including LRRC58/CDO1 cysteine availability studies.</p>
</li>
</ul>
<h2 id="clinical-impact-highlight">Clinical Impact Highlight<a hidden class="anchor" aria-hidden="true" href="#clinical-impact-highlight">#</a></h2>
<p><strong>JAK Inhibitors for Toxic Epidermal Necrolysis</strong></p>
<p>Our 2024 <em>Nature</em> publication (Nordmann TM et al.) on spatial proteomics
identifying JAK inhibitors as treatment for toxic epidermal necrolysis
(TEN) &ndash; a lethal skin disease &ndash; has had immediate clinical impact in 2025. Off-label use of JAK inhibitors in the first patients worldwide
led to complete recovery.</p>
<p><em>&quot;To our knowledge, this is the first time a spatial omics technology
has made an immediate and tangible impact in the clinic, by identifying
a treatment that has already changed people's lives for the good.&quot;</em></p>
<p>&mdash; Matthias Mann</p>
<h2 id="2025-preprints-biorxivmedrxiv">2025 Preprints (bioRxiv/medRxiv)<a hidden class="anchor" aria-hidden="true" href="#2025-preprints-biorxivmedrxiv">#</a></h2>
<ul>
<li>
<p><strong>SPEC workflow</strong> Heymann et al. <em>bioRxiv May 2025</em> Solid-Phase
Extraction Capture for ultrasensitive proteomics</p>
</li>
<li>
<p><strong>nanoPhos</strong> Oliinyk et al. <em>bioRxiv May 2025</em> Cell-type resolved
spatial phosphoproteomics</p>
</li>
<li>
<p><strong>Liver zonation</strong> Weiss et al. <em>bioRxiv Apr 2025</em> Single cell
spatial proteomics of hepatocyte zonation</p>
</li>
<li>
<p><strong>Tree-based proteoform quantification</strong> Ammar et al. <em>bioRxiv Mar
2025</em> Inferring proteoform regulation from bottom-up data</p>
</li>
<li>
<p><strong>ADAPT-MS</strong> Müller-Reif et al. <em>medRxiv May 2025 (in press Nat
Commun)</em> Adaptive clinical diagnostics framework</p>
</li>
<li>
<p><strong>scPortrait</strong> Mädler et al. <em>bioRxiv Sep 2025</em> Single-cell image
integration for multimodal modeling</p>
</li>
<li>
<p><strong>Early ovarian cancer (HGSC)</strong> Metousis et al. <em>medRxiv Aug 2025</em>
Spatial proteomics/transcriptomics integration</p>
</li>
<li>
<p><strong>3D fallopian tube mapping (STIC)</strong> Metousis et al. <em>bioRxiv Sep
2025</em> Multi-omic mapping revealing ovarian cancer precursors</p>
</li>
<li>
<p><strong>Pre-analytical bias</strong> Korff et al. <em>bioRxiv May 2025 (now
published EMBO Mol Med)</em> Bias in bead-enriched plasma proteomics</p>
</li>
</ul>
<h2 id="publication-summary-by-journal">Publication Summary by Journal<a hidden class="anchor" aria-hidden="true" href="#publication-summary-by-journal">#</a></h2>
<hr>
<p><strong>Journal</strong> <strong>Count</strong> <strong>Topics</strong></p>
<hr>
<p><em>Nature</em> 3 Liver disease (DVP), Review,
NNMT/CAFs (w/ Lengyel)</p>
<p><em>Nature Biotechnology</em> 1 AlphaDIA transfer learning</p>
<p><em>Nature Genetics</em> 1 Pediatric plasma proteome</p>
<p><em>Nature Protocols</em> 1 PASEF workflow</p>
<p><em>Nature 1 ADAPT-MS (in press)
Communications</em></p>
<p><em>Cancer Cell</em> 1 Ovarian cancer progression (w/
Lengyel)</p>
<p><em>Cell</em> 1 GPX4 ferroptosis (w/ Conrad)</p>
<p><em>Cell Systems</em> 1 Colon organoid DVP</p>
<p><em>EMBO Mol Med</em> 2 Rare pediatric disorders,
Pre-analytical bias</p>
<p><em>Molecular Cell</em> 1 Tumor-immune crosstalk</p>
<p><em>Mol Cell Proteomics</em> 2 PCA-N plasma, Stellar MS</p>
<p><em>Commun Biol</em> 1 Pancreatic islet cells</p>
<p><em>NPJ Precision Oncol</em> 1 Signet ring cell carcinoma</p>
<p><em>Mol Syst Biol</em> 1 AI laboratory agents</p>
<p><em>J Clin Invest</em> 1 LRRK2 colitis (w/ Yue)</p>
<hr>
<p>For more information: <a href="https://www.biochem.mpg.de/mann">www.biochem.mpg.de/mann</a></p>


</div>



    </main>
    <footer class="footer">
    <span>&copy; 2025 alphapept · Powered by 
        <a href="https://gohugo.io/" rel="noopener noreferrer" target="_blank">Hugo</a> & 
        <a href="https://github.com/adityatelange/hugo-PaperMod/" rel="noopener" target="_blank">PaperMod</a>
        
            · <a href="/imprint/">Imprint</a>
            · <a href="/privacy/">Privacy Policy</a>
        
    </span>
</footer>
</body>

</html>
